110 related articles for article (PubMed ID: 28197753)
1. Asparaginase pharmacology: challenges still to be faced.
Lanvers-Kaminsky C
Cancer Chemother Pharmacol; 2017 Mar; 79(3):439-450. PubMed ID: 28197753
[TBL] [Abstract][Full Text] [Related]
2. Cathepsin B Is Not an Intrinsic Factor Related to Asparaginase Resistance of the Acute Lymphoblastic Leukemia REH Cell Line.
Costa IM; Effer B; Costa-Silva TA; Chen C; Ciccone MF; Pessoa A; Dos Santos CO; Monteiro G
Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446393
[TBL] [Abstract][Full Text] [Related]
3. Towards development of biobetter: L-asparaginase a case study.
Tripathy RK; Anakha J; Pande AH
Biochim Biophys Acta Gen Subj; 2024 Jan; 1868(1):130499. PubMed ID: 37914146
[TBL] [Abstract][Full Text] [Related]
4. Polyoxazoline-Conjugated l-Asparaginase: An Antibody-Production-Free Therapeutic Agent for Acute Lymphoblastic Leukemia.
Yamada T; Ishimaru M; Shoji T; Tomiyasu H; Tochinai R; Taguchi K; Komatsu T
ACS Appl Bio Mater; 2023 Dec; 6(12):5789-5797. PubMed ID: 38047730
[TBL] [Abstract][Full Text] [Related]
5. Development of Escherichia coli asparaginase II for the Treatment of Acute Lymphocytic Leukemia: In Silico Reduction of asparaginase II Side Effects by a Novel Mutant (V27F).
Ardalan N; Akhavan Sepahi A; Khavari-Nejad RA
Asian Pac J Cancer Prev; 2021 Apr; 22(4):1137-1147. PubMed ID: 33906306
[TBL] [Abstract][Full Text] [Related]
6. A dyad of lymphoblastic lysosomal cysteine proteases degrades the antileukemic drug L-asparaginase.
Patel N; Krishnan S; Offman MN; Krol M; Moss CX; Leighton C; van Delft FW; Holland M; Liu J; Alexander S; Dempsey C; Ariffin H; Essink M; Eden TO; Watts C; Bates PA; Saha V
J Clin Invest; 2009 Jul; 119(7):1964-73. PubMed ID: 19509471
[TBL] [Abstract][Full Text] [Related]
7. Enzyme Engineering Strategies for the Bioenhancement of L-Asparaginase Used as a Biopharmaceutical.
Miranda J; Lefin N; Beltran JF; Belén LH; Tsipa A; Farias JG; Zamorano M
BioDrugs; 2023 Nov; 37(6):793-811. PubMed ID: 37698749
[TBL] [Abstract][Full Text] [Related]
8. Quality comparison of a state-of-the-art preparation of a recombinant L-asparaginase derived from Escherichia coli with an alternative asparaginase product.
Schnuchel A; Radcke C; Theobald L; Doeding S
PLoS One; 2023; 18(6):e0285948. PubMed ID: 37319282
[TBL] [Abstract][Full Text] [Related]
9. Novel site-specific PEGylated L-asparaginase.
Meneguetti GP; Santos JHPM; Obreque KMT; Barbosa CMV; Monteiro G; Farsky SHP; Marim de Oliveira A; Angeli CB; Palmisano G; Ventura SPM; Pessoa-Junior A; de Oliveira Rangel-Yagui C
PLoS One; 2019; 14(2):e0211951. PubMed ID: 30753228
[TBL] [Abstract][Full Text] [Related]
10. A protease-resistant Escherichia coli asparaginase with outstanding stability and enhanced anti-leukaemic activity in vitro.
Maggi M; Mittelman SD; Parmentier JH; Colombo G; Meli M; Whitmire JM; Merrell DS; Whitelegge J; Scotti C
Sci Rep; 2017 Nov; 7(1):14479. PubMed ID: 29101342
[TBL] [Abstract][Full Text] [Related]
11. Production and Anticancer Activity of an L-Asparaginase from Bacillus licheniformis Isolated from the Red Sea, Saudi Arabia.
Alrumman SA; Mostafa YS; Al-Izran KA; Alfaifi MY; Taha TH; Elbehairi SE
Sci Rep; 2019 Mar; 9(1):3756. PubMed ID: 30842557
[TBL] [Abstract][Full Text] [Related]
12. A new extracellular glutaminase and urease-free L-asparaginase from Meyerozyma guilliermondii.
Ratuchne A; Izidoro SC; Beitel SM; Lacerda LT; Knob A
Braz J Microbiol; 2023 Jun; 54(2):715-723. PubMed ID: 36917331
[TBL] [Abstract][Full Text] [Related]
13. Heterologous expression of fungal L-asparaginase: a systematic review.
Rodrigues Andrade KC; Cordeiro de Abreu JA; Guimarães MB; Abrunhosa LS; Leôncio Rodrigues AL; Fonseca-Bazzo YM; Silveira D; Souza PM; Magalhães PO
Future Microbiol; 2024 Jan; 19():157-171. PubMed ID: 37882841
[TBL] [Abstract][Full Text] [Related]
14. Recent Strategies and Applications for l-Asparaginase Confinement.
Nunes JCF; Cristóvão RO; Freire MG; Santos-Ebinuma VC; Faria JL; Silva CG; Tavares APM
Molecules; 2020 Dec; 25(24):. PubMed ID: 33321857
[TBL] [Abstract][Full Text] [Related]
15. Engineering and Expression Strategies for Optimization of L-Asparaginase Development and Production.
Shishparenok AN; Gladilina YA; Zhdanov DD
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894901
[TBL] [Abstract][Full Text] [Related]
16. Glutamine mimicry suppresses tumor progression through asparagine metabolism in pancreatic ductal adenocarcinoma.
Recouvreux MV; Grenier SF; Zhang Y; Esparza E; Lambies G; Galapate CM; Maganti S; Duong-Polk K; Bhullar D; Naeem R; Scott DA; Lowy AM; Tiriac H; Commisso C
Nat Cancer; 2024 Jan; 5(1):100-113. PubMed ID: 37814011
[TBL] [Abstract][Full Text] [Related]
17. Homology modeling and molecular docking studies to decrease glutamine affinity of Yarrowia lipolytica L-asparaginase.
Darvishi F; Beiranvand E; Kalhor H; Shahbazi B; Mafakher L
Int J Biol Macromol; 2024 Apr; 263(Pt 2):130312. PubMed ID: 38403216
[TBL] [Abstract][Full Text] [Related]
18. Amino acid depletion triggered by ʟ-asparaginase sensitizes MM cells to carfilzomib by inducing mitochondria ROS-mediated cell death.
Soncini D; Minetto P; Martinuzzi C; Becherini P; Fenu V; Guolo F; Todoerti K; Calice G; Contini P; Miglino M; Rivoli G; Aquino S; Dominietto A; Cagnetta A; Passalacqua M; Bruzzone S; Nencioni A; Zucchetti M; Ceruti T; Neri A; Lemoli RM; Cea M
Blood Adv; 2020 Sep; 4(18):4312-4326. PubMed ID: 32915979
[TBL] [Abstract][Full Text] [Related]
19. Expression and Biological Evaluation of an Engineered Recombinant L-asparaginase Designed by
Dastmalchi M; Alizadeh M; Jamshidi-Kandjan O; Rezazadeh H; Hamzeh-Mivehroud M; Farajollahi MM; Dastmalchi S
Adv Pharm Bull; 2023 Nov; 13(4):827-836. PubMed ID: 38022803
[TBL] [Abstract][Full Text] [Related]
20. A Novel Formulation of Asparaginase Encapsulated into Virus-like Particles of Brome Mosaic Virus: In Vitro and In Vivo Evidence.
Villanueva-Flores F; Pastor AR; Palomares LA; Huerta-Saquero A
Pharmaceutics; 2023 Aug; 15(9):. PubMed ID: 37765229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]